Skip to content

The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st
Stock Photo: Cover May Be Different

The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society (Second Edition) Hard cover - 2017 - 2nd Edition

by Ben Sessa

  • Used
  • very good

Description

Muswell Hill Press, 2017. Hard cover. Very good/No jacket. Second edition. Excellent condition. No visible flaws apart from light handling wear on cover. Inside pages are clean and unmarked.
Used - Very Good
NZ$498.45
NZ$9.14 Shipping to USA
Standard delivery: 5 to 14 days
More Shipping Options
Ships from Moe's Books (California, United States)

About Moe's Books California, United States

Biblio member since 2005
Seller rating: This seller has earned a 5 of 5 Stars rating from Biblio customers.

In business for 50 years, on-line for over 10 years, Telegraph Books is the on-line department of Moe\'s Books in Berkeley. Please direct all questions to our e-mail address books@telegraphbooks.com. Our on-line books can be made available for pick-up at our store, but please contact us by e-mail as they are all warehoused.

Terms of Sale:

We accept Visa, Mastercard, Discover and Amex. Books can be returned for up to 7 days of receipt. Books can be returned when not as described. International shipping as quoted is for items that can be shipped via Global Priority. Oversized or heavier books may require additional postage, quoted at cost.

Browse books from Moe's Books

Details

Categories

About the author

Ben Sessa is a medical doctor and consultant psychiatrist. He is senior research fellow at the University of Bristol, Cardiff University, and Imperial College London, where he is currently conducting the UK's first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence. Dr. Sessa is outspoken on lobbying for change in the current system by which drugs are classified, believing a more progressive policy of regulation would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research. He is a cofounder and director of the UK's Breaking Convention conference.